Login
Companies $HAE
$121.34 +$0.00 (0.0%) After hours
HAEMONETICS CORP logo

HAEMONETICS CORP

haemonetics.com

What Do They Do?

Sells hospital medical technologies, plasma-collection systems and software, and blood-component collection products to hospitals, plasma centers and blood centers.

How Do They Make Money?

Hospitals buy medical devices and related products at shipment or delivery; blood and plasma collectors buy equipment and disposables on that basis, while software support spans service periods and some fees depend on collections or use.

revenue
SegmentShareRevenue
Plasma
39%
Blood Center
Sold outright

17%
Hospital
Sold outright

44%

Who Are Their Customers?

Plasma and blood collection organizations, hospitals and hospital service providers, and purchasing or national health organizations are customers. Sales go through Haemonetics’ direct sales force and independent distributors.

Customers above 10% of revenue, FY2026
of revenue from one customer

Do Revenues Turn Into Profits?

Yes. It kept 7 cents of every revenue dollar as net income in FY2026 and turned 20 cents into free cash flow.

Operating income, FY2026
12% of revenue
▼ −29% vs FY2025 ($221.8M, 16%)
Net income, FY2026
7% of revenue
▼ −42% vs FY2025 ($167.7M, 12%)
Free cash flow, FY2026
20% of revenue
▲ +83% vs FY2025 ($142.4M, 10%)

How Are They Changing?

Since the FY2026 annual report
Latest quarter: Q2 FY2027, the three months to Sep 26, 2026
Revenue
▲ +9%
vs $327.3M in Q2 FY2026
Net income
▲ +20%
vs $38.7M in Q2 FY2026
  • Aug 6, 2026 Raised full-year revenue guidance Haemonetics raised its previous revenue and organic revenue growth guidance.

Growing. Revenue grew 34% in 4 years, from $993.2M in FY2022 to $1.3B in FY2026, about 8% a year.

Blood Center product line The older report describes manual whole-blood collection systems and disposable sets; the newer report says the Whole Blood product line was divested and describes automated component systems.

Hospital product range The newer report adds sensor-guided technologies and esophageal protection to the Hospital portfolio, alongside vascular closure, hemostasis management, cell salvage and transfusion management.

Revenue over time
Plasma Blood Center Hospital
$2B$1B$0

Who Do They Compete With?

Competes with Fresenius, Terumo Blood and Cell Technologies, Abbott Laboratories, Nigale, Scinomed, Cordis, Teleflex, Boston Scientific, Philips, Werfen, Diagnostica Stago, Sysmex, HemoSonics, LivaNova, Medtronic, WellSky, SSC Soft, Cerner, Clinsys, and MSoft

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support